Lorad scores deal with U.S. Surgical

Article

Mammography vendor Lorad of Danbury, CT, has signed an exclusivemultiyear agreement with breast biopsy instrument supplier U.S.Surgical that could be worth up to $10 million to Lorad in thefirst year of the contract. Under the terms of the deal,

Mammography vendor Lorad of Danbury, CT, has signed an exclusivemultiyear agreement with breast biopsy instrument supplier U.S.Surgical that could be worth up to $10 million to Lorad in thefirst year of the contract. Under the terms of the deal, Loradwill supply stereotactic equipment such as its StereoGuide coreneedle biopsy system to U.S. Surgical for use with that company'sAdvanced Breast Biopsy Instrument (ABBI) system. ABBI employsa one-step procedure to both place a wire marker in the breastand remove a tissue specimen for biopsy.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.